Lyra Therapeutics Inc LYRA
$0.50 $0.83 (62.50%) 1D
Last Updated: Mar 16, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
LYRA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Lyra Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Lyra Therapeutics Inc. Stock Analysis LYRA
United States Health Care Nano Cap Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. The company is headquartered in Watertown, Massachusetts and currently employs 27 full-time employees. The company went IPO on 2020-05-01. The firm is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). The firm is developing therapies for CRS, a prevalent inflammatory disease of the paranasal sinuses that leads to debilitating symptoms and significant morbidities. LYR-210, the Company’s lead product, is a bioabsorbable nasal implant designed to be administered in a simple, in-office procedure and is intended to deliver six months of continuous anti-inflammatory drug therapy to the sinonasal passages for the treatment of CRS with a single administration. LYR-210, being evaluated in the ENLIGHTEN Phase III clinical program, is intended for patients with and without nasal polyps. The drug embedded within LYR-210 is mometasone furoate (MF).
Lyra Therapeutics Inc (LYRA) Chart
Financial Metrics & Statements of Lyra Therapeutics Inc (LYRA)
FAQ's for Lyra Therapeutics Inc (LYRA)
- As of August 2026, Lyra Therapeutics Inc LYRA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lyra Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Lyra Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Lyra Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Lyra Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Lyra Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Lyra Therapeutics Inc (LYRA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
